364 related articles for article (PubMed ID: 30411372)
1. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
[TBL] [Abstract][Full Text] [Related]
2. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
[TBL] [Abstract][Full Text] [Related]
3. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.
Calkins KL; Dunn JC; Shew SB; Reyen L; Farmer DG; Devaskar SU; Venick RS
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):682-92. PubMed ID: 23894176
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 122 Reflects Liver Injury in Children with Intestinal Failure-Associated Liver Disease Treated with Intravenous Fish Oil.
Calkins KL; Thamotharan S; Ghosh S; Dai Y; Devaskar SU
J Nutr; 2020 May; 150(5):1144-1150. PubMed ID: 32072161
[TBL] [Abstract][Full Text] [Related]
5. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
Khan FA; Fisher JG; Sparks EA; Potemkin A; Duggan C; Raphael BP; Modi BP; Jaksic T
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580
[TBL] [Abstract][Full Text] [Related]
6. Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.
Yu LJ; Anez-Bustillos L; Mitchell PD; Ko VH; Secor JD; Hurley AP; Dao DT; Fligor SC; Cho BS; Tsikis ST; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):30-40. PubMed ID: 36308408
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Fish Oil and Pediatric Intestinal Failure-Associated Liver Disease: Changes in Plasma Phytosterols, Cytokines, and Bile Acids and Erythrocyte Fatty Acids.
Calkins KL; DeBarber A; Steiner RD; Flores MJ; Grogan TR; Henning SM; Reyen L; Venick RS
JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):633-641. PubMed ID: 28521607
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
9. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
[TBL] [Abstract][Full Text] [Related]
10. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
11. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Cheung HM; Lam HS; Tam YH; Lee KH; Ng PC
Clin Nutr; 2009 Apr; 28(2):209-12. PubMed ID: 19261360
[TBL] [Abstract][Full Text] [Related]
12. Effect of a fish oil-based lipid emulsion on intestinal failure-associated liver disease in children.
Zhang T; Wang N; Yan W; Lu L; Tao Y; Li F; Wang Y; Cai W
Eur J Clin Nutr; 2018 Oct; 72(10):1364-1372. PubMed ID: 29382923
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
Rochling FA
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
[TBL] [Abstract][Full Text] [Related]
14. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Fish Oil and Serum Fatty Acid Profiles in Pediatric Patients With Intestinal Failure-Associated Liver Disease.
Ong ML; Venick RS; Shew SB; Dunn JCY; Reyen L; Grogan T; Calkins KL
JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):717-725. PubMed ID: 30900274
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
Nandivada P; Fell GL; Mitchell PD; Potemkin AK; O'Loughlin AA; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):930-937. PubMed ID: 26962059
[TBL] [Abstract][Full Text] [Related]
17. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).
Chang MI; Puder M; Gura KM
Nutrients; 2012 Nov; 4(12):1828-50. PubMed ID: 23363993
[TBL] [Abstract][Full Text] [Related]
18. Reversal of Intestinal Failure-Associated Liver Disease by Switching From a Combination Lipid Emulsion Containing Fish Oil to Fish Oil Monotherapy.
Lee S; Park HJ; Yoon J; Hong SH; Oh CY; Lee SK; Seo JM
JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):437-40. PubMed ID: 25560679
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Failure-Associated Liver Disease and Growth Pre- and Post-Transition to a Composite Lipid Emulsion.
Hudson AS; Tyminski N; Turner JM; Silverman JA
J Pediatr Gastroenterol Nutr; 2023 Jun; 76(6):830-836. PubMed ID: 36930972
[TBL] [Abstract][Full Text] [Related]
20. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
